Biotech using computational models to predict and reprogram biochemical interactions for faster drug discovery.
| Date | Round | Amount |
|---|---|---|
| Dec 2025 | Funding round Chai Discovery raised $130 million at a $1.3 billion valuation, with Oak HC/FT, General Catalyst, Thrive, Menlo and OpenAI, bringing the total to $225 million for its AI molecular design suite. | $130M |
| Aug 2025 | Series A Chai Discovery closed a $70 million Series A led by Menlo Ventures through the Anthology Fund with Anthropic, to accelerate the development of therapies via computational models. | $70M |